PharmaVentures has announced the launch of a brand new internet-based television show: PharmaVentures Business Review
Dr Fintan Walton, CEO, PharmaVentures, says, ‘This show, the first in a monthly series, provides viewers across the pharmaceutical and biotechnology sectors with insightful analysis and debate covering major transactions and industry trends. It gives exclusive access to topical interviews with senior executives and experts, including views from the corporate finance sector.’
In addition to providing lively coverage of news and current affairs in the industry, and a review of market trends, this first edition of Business Review features interviews with key players in the financing of Australian biotech companies, as well as a round-table discussion focusing on Mergers and Acquisitions in the pharmaceutical and biotechnology sectors.
Dr Fintan Walton leads a discussion with an expert panel involving: Glyn Edwards, CEO, Antisoma; Charles Macfarlane, Executive Director Worldwide Alliances, Licensing and Acquisitions, Procter and Gamble; Ulrich Kinzel, Director, Nomura Code Securities.
Issues debated include recent trends and whether M&As actually work.
Just to quash any rumors before they start, Insider has no plans, at this stage, of becoming a TV star.
Oh, and by the way, Fintan, get a decent haircut!
No comments:
Post a Comment